Form 4 for PDSB PDS Biotechnology Corp
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-28 · accession 0001140361-25-006784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-28 | PDSB | Freitag Gregory Gene | Dir | P - Purchase | $1.66 | +15.1K | 61.2K | +33% | +$25.0K |
| D | 2025-03-03 | 2025-02-28 | PDSB | Freitag Gregory Gene | Dir | P - Purchase | — | +15.1K | 15.1K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | P | A | 15,060 | $1.66 | 61,213 | D | — | — | |
| 2 | Derivative | Common Warrant | 2025-02-28 | P | A | 15,060 | — | 15,060 | D | $1.53 · 2025-02-28 to 2030-02-28 | 15,060 Common Stock | (F1) The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above. |